Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells

1 month ago

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related…

Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program

1 month ago

BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company…

UniDoc Receives Order for Health Cubes

1 month ago

Three units for demonstration within Verizon Innovation Labs VANCOUVER, BC / ACCESS Newswire / November 25, 2025 / UniDoc Health…

Lexicon Pharmaceuticals to Participate in Two Upcoming December Investor Conferences

1 month ago

THE WOODLANDS, Texas, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will…

PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025

1 month ago

Internationally recognized colorectal surgeon Steven D. Wexner, MD, FACS, FRCS, to discuss the clinical and economic burden of surgical site…

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Anticipates Major Fair-Value Uptick Following New Independent JV Valuation

1 month ago

NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- via BioMedWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement…

As UnitedHealthcare Scales Back Traditional RPM, Addison(R) Virtual Caregiver Signals the Next Phase of Home-Based Care

1 month ago

Electronic Caregiver's 24/7 virtual caregiving platform steps forward just as payers move away from low-engagement, device-only monitoring. LAS CRUCES, NM…

LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment

1 month ago

Located at the Daresbury site of the renowned UK-based Science and Technology Facilities Council (STFC), with $300+ million invested to…

Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS

1 month ago

Publication details large multicenter clinical trial demonstrating significant reductions in IBS symptoms through inFoods IBS guided dietary therapy IRVINE, Calif.,…

Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®

1 month ago

Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP), the European Commission has granted marketing…